blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1007052

EP1007052 - COMBINATIONS OF ENDOMETRIAL SPARING PROGESTINS AND ENDOMETRIAL ATROPHIZING PROGESTINS WITH ESTROGENS, IN ORAL CONTRACEPTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.08.2005
Database last updated on 23.04.2024
Most recent event   Tooltip19.08.2005No opposition filed within time limitpublished on 05.10.2005  [2005/40]
Applicant(s)For all designated states
Ortho-McNeil Pharmaceutical, Inc.
U.S. Route No. 202
Raritan, NJ 08869-0606 / US
[2004/40]
Former [2000/24]For all designated states
ORTHO PHARMACEUTICAL CORPORATION
U.S Route 22 Nr.202
Raritan, NJ 08869-0602 / US
Inventor(s)01 / KAFRISSEN, Michael
P.O. Box 165
Gladstone, NJ 07934 / US
02 / TAITEL, Haya
4 Lincroft Drive
Gladstone, NJ 07934 / US
[2000/24]
Representative(s)Mercer, Christopher Paul, et al
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [2000/24]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date98942166.420.08.1998
[2000/24]
WO1998US17288
Priority number, dateUS19970057109P27.08.1997         Original published format: US 57109 P
[2000/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9909993
Date:04.03.1999
Language:EN
[1999/09]
Type: A1 Application with search report 
No.:EP1007052
Date:14.06.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.1999 takes the place of the publication of the European patent application.
[2000/24]
Type: B1 Patent specification 
No.:EP1007052
Date:13.10.2004
Language:EN
[2004/42]
Search report(s)International search report - published on:EP04.03.1999
ClassificationIPC:A61K31/56, A61P15/18
[2004/18]
CPC:
A61K31/565 (EP); A61P15/18 (EP)
C-Set:
A61K31/565, A61K2300/00 (EP);
A61K31/565, A61K31/565 (EP)
Former IPC [2000/24]A61K31/56
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/24]
TitleGerman:KOMBINATIONEN VON ENDOMETRIUM SCHONENDEN GESTAGENEN UND ENDOMETRIUM ATROPHISIERENDEN GESTAGENEN MIT ESTROGENEN, BEI DER ORALEN EMPFÄNGNISVERHÜTUNG[2000/24]
English:COMBINATIONS OF ENDOMETRIAL SPARING PROGESTINS AND ENDOMETRIAL ATROPHIZING PROGESTINS WITH ESTROGENS, IN ORAL CONTRACEPTION[2000/24]
French:ASSOCIATIONS DE PROGESTATIFS CONSERVANT L'ENDOMETRE ET DE PROGESTATIFS ATROPHIANT L'ENDOMETRE AVEC DES OESTROGENES, DESTINEES A LA CONTRACEPTION ORALE[2000/24]
Entry into regional phase16.03.2000National basic fee paid 
16.03.2000Designation fee(s) paid 
16.03.2000Examination fee paid 
Examination procedure08.03.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
16.03.2000Examination requested  [2000/24]
06.06.2001Despatch of a communication from the examining division (Time limit: M04)
10.10.2001Reply to a communication from the examining division
15.10.2003Despatch of a communication from the examining division (Time limit: M04)
25.02.2004Reply to a communication from the examining division
24.03.2004Communication of intention to grant the patent
29.07.2004Fee for grant paid
29.07.2004Fee for publishing/printing paid
Opposition(s)14.07.2005No opposition filed within time limit [2005/40]
Fees paidRenewal fee
16.03.2000Renewal fee patent year 03
14.08.2001Renewal fee patent year 04
14.08.2002Renewal fee patent year 05
13.08.2003Renewal fee patent year 06
12.08.2004Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]US4390531  (EDGREN RICHARD A) [DA] 1-17 * abstract *;
 [DA]US4616006  (PASQUALE SAMUEL A [US]) [DA] 1-17* abstract *;
 [DA]US4921843  (PASQUALE SAMUEL A [US]) [DA] 1-17 * abstract *;
 [DA]US5280023  (EHRLICH MARIKA [DE], et al) [DA] 1-17 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.